All members have the option of attending our various HTC-centric events which include:
Date: Wednesday, October 1st, 2025
Time: 1:00pm – 2:00pm ET
WEBINAR TOPIC:
On-demand and Surgical Use of ADVATE® [Antihemophilic Factor (Recombinant)]
Jessica Grandoni, Pharm.D., BCPS, was the Hemostatic Antithrombotic Stewardship Lead Pharmacist (HAT), and clinical pharmacy specialist, at Brigham and Women’s Hospital in Boston, Massachusetts. She is now a clinical pharmacy specialist at the Dana Farber Cancer Institute’s Anticoagulation Management Service.
Jessica has been involved in several committees and initiatives related to her practice interests of anticoagulation therapy and reversal, heparin induced thrombocytopenia, mechanical circulatory support, drug formulary management and associated guidelines. She is involved in research, education, and publications with pharmacy, hematology, cardiology, and the mechanical circulatory support division. She has published one of the top downloaded articles with the American Journal of Hematology and has presented at national and international conferences. Jessica earned her Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Health Sciences University in Boston and completed an ASHP-accredited Post Graduate Year 1 residency at Beth Israel Deaconess Medical Center. She also completed an ASHP-accredited Post Graduate Year 2 cardiology residency at The University of California Davis Medical Center with a focus in anticoagulation and reversal.
